Cisplatin nephropathy: is cytotoxicity avoidable?
Razzaque
M Shawkat
MS
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000517:prevention & control*; D048670:MAP Kinase Kinase 4 / Q000378:metabolism; D008954:Models, Biological; D051381:Rats; D013552:Swine
D000970:Antineoplastic Agents; D048670:MAP Kinase Kinase 4; D002945:Cisplatin